The Effect of a Passive Hip Exoskeleton on Daily-life Fatigue in Older Adults
Evaluating and Monitoring Physical Fatigue While Performing Functional Activities
1 other identifier
interventional
15
1 country
1
Brief Summary
This crossover study investigates whether a passive lower-limb exoskeleton (Exoband) can reduce perceived exertion during everyday mobility tasks in older adults. Participants complete the fatigue protocol- a structured sequence of daily challenging tasks (e.g., overground walking, stair and slope walking, obstacle avoidance)-once with the Exoband and once without it, in randomized order and separated by a one-week washout period. During each session, distance covered until fatigue, rate of perceived exertion, physiological and gait parameters are recorded. The aim is to determine whether exoskeleton assistance enhances mobility performance and reduces functional fatigue across older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2025
CompletedStudy Start
First participant enrolled
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
January 22, 2026
January 1, 2026
6 months
December 10, 2025
January 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in the Ratings of Perceived Exertion throughout the protocol execution
The subjective feelings of fatigue will be evaluated through the Ratings of Perceived Exertion, using the modified Borg Scale (score ranging from 0 'no exertion' to 10 'maximal exertion'). This will be expressed verbally by the participant throughout the execution of the protocol.
Through study completion, an average of 1-2 weeks.
Secondary Outcomes (6)
Changes in muscle activity (surface EMG) throughout the protocol execution
Through study completion, an average of 1-2 weeks.
Changes in heart rate (variability) (ECG sensors) throughout the protocol execution
Through study completion, an average of 1-2 weeks.
Changes in muscle oxygen saturation (Moxy Monitor) throughout the protocol execution
Through study completion, an average of 1-2 weeks.
Changes in electrodermal activity (Galvanic Skin Response - finger electrodes) throughout the protocol execution
Through study completion, an average of 1-2 weeks.
Changes in motion data (IMU sensors) throughout the protocol execution
Through study completion, an average of 1-2 weeks.
- +1 more secondary outcomes
Study Arms (2)
Exoband ON
ACTIVE COMPARATORThe participants execute the fatigue protocol while wearing the passive hip exoskeletons (Exoband).
Exoband OFF
PLACEBO COMPARATORThe participants execute the fatigue protocol without wearing the passive hip exoskeletons (Exoband).
Interventions
The participant will wear the Exoband (Moveo), which is a lightweight, soft wearable exoskeleton designed to assist walking by providing elastic support to the hip during gait. It uses passive elastic elements to store and release energy in sync with the user's movement, reducing muscular effort without motors or batteries. The system is unobtrusive and aims to support mobility while preserving natural movement patterns.
The participant will be asked to execute a protocol in the movement lab that induces progressive feelings of fatigue. This protocol includes a sequence of relevant functional activities, such as stair walking, slope walking, crouching, walking different path shapes. During this execution the Ratings of Perceived Exertion will be questioned, and simultaneously physiological and movement data will be collected.
Eligibility Criteria
You may qualify if:
- \> 65 years old
- Healthy physical condition
You may not qualify if:
- Physical injury or disorder that doesn't allow good physical performance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brubotics Rehabilitation Research Center
Jette, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Beckwée, PhD
Vrije Universiteit Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 10, 2025
First Posted
January 22, 2026
Study Start
December 11, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
January 22, 2026
Record last verified: 2026-01